Needham maintains Equifax at Buy, raises price target to $220 from $210

Needham reaffirmed its Buy rating for Equifax and increased its price target to $220 from $210, citing a 16.9% upside from the Nov 13 close of $188.12. Recent analyst price targets for Equifax range from $175 to $217.

Original reporting
Published Nov 16, 2026, 11:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Needham maintains Equifax at Buy, raises price target to $220 from $210 — source image
Decision brief

The 30-second read

$EFXBullishMed
01

Why it matters

The upward revision signals confidence in earnings growth or market positioning, which could prompt buying interest.

02

Market read

A new analyst price target can move the stock modestly, offering a short‑term trading cue.

03

What to watch

Potential regulatory scrutiny on credit bureaus could offset the bullish signal.

Relevance 7/10Novelty 7/10Timing: today

Background

Equifax (EFX) is a leading consumer credit reporting agency. Analyst price target changes often influence short‑term sentiment.

Company-level read

Ticker impact

$EFXBullishHigh confidence
Context

Needham raised Equifax's price target to $220 from $210, indicating a bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target implies a 16.9% upside from the recent close, which may attract buying.

Market effects

Credit reporting sector may see modest uplift as a major player receives a higher target.

U.S. markets could see slight positive bias in financial services stocks.

Limited to investors tracking U.S. credit data providers.

Counterpoint

The target raise may already be priced in, limiting upside.

Key entities

  • Needham & Company

    Equity research firm that issued the rating and target update.

  • Equifax Inc.

    U.S. consumer credit reporting company.

Related articles

$EFXLow

Equifax's $100 Million Credit Score Settlement Could Pay Up to $280 Each to People Whose Scores Were Misreported in 2022, With Claims Due Dec. 28

Equifax has agreed to a $100 million settlement for misreported credit scores in 2022, affecting about 4 million people. Affected individuals can claim up to $280 each by Dec. 28, 2026. Equifax denies wrongdoing but settled to resolve the issue. The settlement covers those whose incorrect scores were sent to lenders during mortgage, auto loan, or credit card applications.

$EFXMed

Why Equifax (EFX) stock is down today

Equifax (EFX) shares fell 2.7% after RBC downgraded the stock to Sector Perform and raised its price target to $189. The downgrade cited valuation concerns and operating issues, including mortgage market weakness and regulatory risks. The stock later recovered slightly to $178.03, down 2.4%. Equifax's shares are down 16.8% year-to-date and 22.3% below their 52-week high.

$LMTHighAI 8/10

Lockheed Martin, Blackstone and P&G Beat Q3 Estimates as $14 Billion Deal Wave and $317.5 Million IPO Reshape US Markets

Lockheed Martin (LMT) reported Q3 EPS of $7.97, beating estimates, and raised its full-year revenue forecast to $80B-$82B. Blackstone (BX) beat EPS estimates with $1.32, and shares rose 8.4%. Procter & Gamble (PG) reported Q1 EPS of $2.00, beating estimates, with sales up 4%. Equifax (EFX) saw Q3 revenue rise 10%, with mortgage revenue up 15%, despite market weakness. Shares of all companies rose following earnings reports.